Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 582,131 | 427,792 | 377,047 | 263,269 | 222,054 |
| Depreciation Amortization | 95,998 | 88,011 | 83,178 | 83,140 | 79,061 |
| Income taxes - deferred | -38,082 | 6,162 | 1,209 | -7,918 | 20,881 |
| Accounts receivable | -60,722 | -22,472 | -18,401 | -24,918 | -22,554 |
| Accounts payable and accrued liabilities | 981 | 1,957 | -166 | 1,391 | 2,117 |
| Other Working Capital | -31,761 | -104,969 | -91,640 | 8,380 | 7,374 |
| Other Operating Activity | 99,518 | 62,677 | 48,857 | 49,932 | 30,010 |
| Operating Cash Flow | $648,063 | $459,158 | $400,084 | $373,276 | $338,943 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -250 | N/A | 284,038 | -47,405 | -24,035 |
| PPE Investments | -106,958 | -154,969 | -115,751 | -74,384 | -64,787 |
| Net Acquisitions | -1,500 | -50,304 | -22,500 | -14,579 | -1,964 |
| Purchase Sale Intangibles | -668 | -255 | -7,185 | -2,320 | N/A |
| Other Investing Activity | -668 | -255 | -7,185 | -2,320 | 0 |
| Investing Cash Flow | $-109,376 | $-205,528 | $138,602 | $-138,688 | $-90,786 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -289,625 | -110,275 | N/A | 44,000 | 38,000 |
| Debt Issued | 200,000 | 100,000 | N/A | N/A | N/A |
| Common Stock Issued | 51,328 | 36,106 | 38,201 | 38,622 | 38,344 |
| Common Stock Repurchased | -203,418 | -309,711 | -378,694 | -290,638 | -308,458 |
| Other Financing Activity | -6,701 | -2,529 | -257,306 | 0 | 9,918 |
| Financing Cash Flow | $-248,416 | $-286,409 | $-597,799 | $-208,016 | $-222,196 |
| Exchange Rate Effect | 3,331 | -689 | -4,768 | 6,202 | -54 |
| Beginning Cash Position | 90,326 | 123,794 | 187,675 | 154,901 | 128,994 |
| End Cash Position | 383,928 | 90,326 | 123,794 | 187,675 | 154,901 |
| Net Cash Flow | $293,602 | $-33,468 | $-63,881 | $32,774 | $25,907 |
| Free Cash Flow | |||||
| Operating Cash Flow | 648,063 | 459,158 | 400,084 | 373,276 | 338,943 |
| Capital Expenditure | -106,958 | -154,969 | -115,751 | -74,384 | -64,787 |
| Free Cash Flow | 541,105 | 304,189 | 284,333 | 298,892 | 274,156 |